Biotech stocks have fallen to earth with a thud in 2021 after soaring last year amid excitement over the development of Covid-19 vaccines, dealing big losses to some hedge funds.
The sector is being buffeted by concerns Congress will move to put a lid on drug pricing and a surfeit of early-stage biotech shares as the IPO market booms.
Studying Time: 2 minutes Diana Areas, the famed bodybuilder and social media influencer, has handed away on the age of…
SAN ANTONIO — Steph Curry shook up the basketball shoe world on…
Survey Says is a weekly collection rounding up a very powerful polling…
Chinese artificial-intelligence company SenseTime Group Inc. said it would postpone…
